Prochlorperazine Edisylate Injection
Product Images NDC 51662-1558

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Edisylate (NDC 51662-1558). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Labeling (51662 1558 2 Pouch Label)

Label for PROCHLORPERAZINE EDISYLATE injection, 5 mg/mL strength, in a 2 mL vial. The label specifies usage for intramuscular and intravenous injection, includes NDC code 51662-1558, lot number, and expiration date. Manufactured by HF Acquisition Co LLC, with storage instructions and active ingredient details noted.*

FDA Label Image

Case Labeling (51662 1558 3 Case Labeling)

Label for PROCHLORPERAZINE EDISYLATE Injection 5 mg/mL in a 2 mL vial. The label includes NDC 51662-1558-3, manufacturer HF Acquisition Co LLC, and states it is for intramuscular or intravenous use only. The label provides lot number, expiration date, and storage instructions (20° to 25°C). The product is prescription only and not for subcutaneous use.*

FDA Label Image

Rfid Labeling (51662 1558 3 Rfid Label)

A small white rectangular label with a barcode and several numeric codes. The label includes text indicating distribution by HF Acquisition Co, LLC, located in Mukilteo, WA. The label is affixed to a clear or translucent surface with a metallic strip on top.*

FDA Label Image

Boxed Warning (Boxed Warning)

Warning panel from PROCHLORPERAZINE EDISYLATE Injection, USP describing increased mortality risk in elderly patients with dementia-related psychosis treated with antipsychotic drugs, summarizing findings from clinical trials and observational studies.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Prochlorperazine Edisylate including its molecular formula (C20H24ClN3S • C2H6O6S2) and molecular weight (MW 564.14). The diagram shows the individual atoms and bonding typical of the compound's active ingredient.*

FDA Label Image

Vial Label (Vial Label)

Label for Prochlorperazine Edisylate Injection, USP 10 mg/2 mL (5 mg/mL) in a 2 mL multiple-dose vial. The label indicates the injection is for deep intramuscular or intravenous use only, not for subcutaneous use. Manufactured by Emcure Pharmaceuticals Ltd., India, for Avet Pharmaceuticals Inc. The label includes a barcode and storage instruction to protect from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.